Annual Working Capital
$358.99 M
+$34.10 M+10.50%
December 31, 2023
Summary
- As of February 8, 2025, RCKT annual working capital is $358.99 million, with the most recent change of +$34.10 million (+10.50%) on December 31, 2023.
- During the last 3 years, RCKT annual working capital has fallen by -$95.74 million (-21.05%).
- RCKT annual working capital is now -21.05% below its all-time high of $454.73 million, reached on December 31, 2020.
Performance
RCKT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$201.77 M
-$53.36 M-20.91%
September 30, 2024
Summary
- As of February 8, 2025, RCKT quarterly working capital is $201.77 million, with the most recent change of -$53.36 million (-20.91%) on September 30, 2024.
- Over the past year, RCKT quarterly working capital has dropped by -$211.62 million (-51.19%).
- RCKT quarterly working capital is now -55.63% below its all-time high of $454.73 million, reached on December 31, 2020.
Performance
RCKT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
RCKT Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.5% | -51.2% |
| 3 y3 years | -21.1% | -51.2% |
| 5 y5 years | +85.3% | -51.2% |
RCKT Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.0% | +10.5% | -51.2% | at low |
| 5 y | 5-year | -21.1% | +24.0% | -55.6% | +0.3% |
| alltime | all time | -21.1% | >+9999.0% | -55.6% | +5780.6% |
Rocket Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $201.77 M(-20.9%) |
| Jun 2024 | - | $255.13 M(-18.3%) |
| Mar 2024 | - | $312.20 M(-5.3%) |
| Dec 2023 | $358.99 M(+10.5%) | $329.72 M(-20.2%) |
| Sep 2023 | - | $413.39 M(+48.8%) |
| Jun 2023 | - | $277.73 M(-9.5%) |
| Mar 2023 | - | $306.83 M(-5.6%) |
| Dec 2022 | $324.89 M(-12.2%) | $324.89 M(+15.6%) |
| Sep 2022 | - | $280.95 M(-6.8%) |
| Jun 2022 | - | $301.48 M(-9.0%) |
| Mar 2022 | - | $331.28 M(-10.4%) |
| Dec 2021 | $369.89 M(-18.7%) | $369.89 M(-7.7%) |
| Sep 2021 | - | $400.58 M(-1.1%) |
| Jun 2021 | - | $404.98 M(-6.1%) |
| Mar 2021 | - | $431.33 M(-5.1%) |
| Dec 2020 | $454.73 M(+57.1%) | $454.73 M(+125.9%) |
| Sep 2020 | - | $201.26 M(-14.3%) |
| Jun 2020 | - | $234.75 M(-9.3%) |
| Mar 2020 | - | $258.69 M(-10.6%) |
| Dec 2019 | $289.44 M | $289.44 M(+29.6%) |
| Sep 2019 | - | $223.41 M(-10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $248.55 M(+38.8%) |
| Mar 2019 | - | $179.05 M(-7.6%) |
| Dec 2018 | $193.72 M(+99.8%) | $193.72 M(+63.4%) |
| Sep 2018 | - | $118.53 M(-4.8%) |
| Jun 2018 | - | $124.46 M(-29.9%) |
| Mar 2018 | - | $177.49 M(+83.0%) |
| Dec 2017 | $96.98 M(-20.1%) | $96.98 M(-3.1%) |
| Sep 2017 | - | $100.11 M(-5.4%) |
| Jun 2017 | - | $105.81 M(-5.0%) |
| Mar 2017 | - | $111.36 M(-8.2%) |
| Dec 2016 | $121.31 M(+12.1%) | $121.31 M(-8.8%) |
| Sep 2016 | - | $132.98 M(+40.5%) |
| Jun 2016 | - | $94.63 M(-4.1%) |
| Mar 2016 | - | $98.63 M(-8.9%) |
| Dec 2015 | $108.22 M(-3146.9%) | $108.22 M(-6.7%) |
| Sep 2015 | - | $115.98 M(+146.6%) |
| Jun 2015 | - | $47.02 M(-7.8%) |
| Mar 2015 | - | $50.98 M(-1535.3%) |
| Dec 2014 | -$3.55 M(-136.8%) | -$3.55 M(-283.6%) |
| Sep 2014 | - | $1.94 M(-79.9%) |
| Dec 2013 | $9.64 M(-510.6%) | $9.64 M |
| Dec 2012 | -$2.35 M | - |
FAQ
- What is Rocket Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual working capital year-on-year change?
- What is Rocket Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly working capital year-on-year change?
What is Rocket Pharmaceuticals annual working capital?
The current annual working capital of RCKT is $358.99 M
What is the all time high annual working capital for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual working capital is $454.73 M
What is Rocket Pharmaceuticals annual working capital year-on-year change?
Over the past year, RCKT annual working capital has changed by +$34.10 M (+10.50%)
What is Rocket Pharmaceuticals quarterly working capital?
The current quarterly working capital of RCKT is $201.77 M
What is the all time high quarterly working capital for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly working capital is $454.73 M
What is Rocket Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, RCKT quarterly working capital has changed by -$211.62 M (-51.19%)